New Delhi : Only 5 percent pregnant women get counselling for thyroid disorders
New Delhi : Only five percent of India's women get counselling for thyroid disorders during pregnancy, increasing the risk of a slew of medical complications, including miscarriages and postpartum bleeding, a white paper on the issue said.
It also said that less than one percent women in both public and private hospitals get complete Thyroid Panel tests routinely done currently in the country.
The prevalence of thyroid diseases in India currently was 10.95 percent, almost double the diabetes cases at 5.4 percent of the country's population.
Treating hypothyroidism is costlier than abortion it triggers, said the white paper.
The white paper on 'Impact and Assessment of Thyroid and Influenza disorders on Mother and Child Health' was jointly launched by business chamber FICCI and Frost and Sullivan, a company working to address global challenges.
It said there was not much difference between public health service providers and private healthcare settings when it comes to screening for thyroid.
The prevalence of thyroid screening ranges between 5-10 percent in government hospitals and 20-25 percent in private hospitals.
The impact of thyroid disorders is not visible early enough; however, optimum levels of thyroid hormones during the first three months of pregnancy are critical for the brain development in foetuses.
In India, hypothyroidism rate is 1 in 800 neonates as against a global average of 1 in 3,800.
The white paper also advocated the urgent need for influenza vaccination for all pregnant women.
"A significant number of clinicians interviewed endorsed the need for screening test for thyroid disorders and most agreed to give flu vaccinations to pregnant women. Currently it is a gap area and many hospitals do not do this routinely," said Ankita Kothari, industry analyst, Frost and Sullivan.
Vandana Gurnani, joint secretary in the Ministry of Health and Family Welfare, said: "India has made tremendous progress in bringing down maternal and child mortality, made possible by multiple interventions at various stages before, during and after pregnancies."
It also said that less than one percent women in both public and private hospitals get complete Thyroid Panel tests routinely done currently in the country.
The prevalence of thyroid diseases in India currently was 10.95 percent, almost double the diabetes cases at 5.4 percent of the country's population.
Treating hypothyroidism is costlier than abortion it triggers, said the white paper.
The white paper on 'Impact and Assessment of Thyroid and Influenza disorders on Mother and Child Health' was jointly launched by business chamber FICCI and Frost and Sullivan, a company working to address global challenges.
It said there was not much difference between public health service providers and private healthcare settings when it comes to screening for thyroid.
The prevalence of thyroid screening ranges between 5-10 percent in government hospitals and 20-25 percent in private hospitals.
The impact of thyroid disorders is not visible early enough; however, optimum levels of thyroid hormones during the first three months of pregnancy are critical for the brain development in foetuses.
In India, hypothyroidism rate is 1 in 800 neonates as against a global average of 1 in 3,800.
The white paper also advocated the urgent need for influenza vaccination for all pregnant women.
"A significant number of clinicians interviewed endorsed the need for screening test for thyroid disorders and most agreed to give flu vaccinations to pregnant women. Currently it is a gap area and many hospitals do not do this routinely," said Ankita Kothari, industry analyst, Frost and Sullivan.
Vandana Gurnani, joint secretary in the Ministry of Health and Family Welfare, said: "India has made tremendous progress in bringing down maternal and child mortality, made possible by multiple interventions at various stages before, during and after pregnancies."
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.